PIPELINE OVERVIEW
We have a robust drug development pipeline at various clinical and preclinical stages.
Tap the sections below to expand or download the full pipeline chart.
LAST STAGE
INVESTOR INITIATED IO
OTHER ONCOLOGY PIPELINE
BeyondSpring Subsidiaries: 1) Dalian Wanchunbulin Pharmaceuticals Ltd., which owns China rights to Plinabulin, and 2) Seed Therapeutics, a target protein degradation company.